Not medical advice. This site does arithmetic and reports published information. It never tells you what dose to take. Talk to a licensed provider.
Peptide Ratio Submit PR·SUBMIT.SITE
Animal-onlyNot approvedCJC-1295 (with or without DAC)

CJC-1295

A growth-hormone-releasing analog, often stacked with ipamorelin. Minimal human data.

Class
GHRH analog
Common stack
With ipamorelin
Variants
With or without DAC
Half-life
Short; longer with DAC
Human PK
Very limited
FDA status
Not approved
Sport status
Prohibited
Established dose
None exists
Human evidenceAnimal-only
Read this first

There is no clinically validated human dose you can look up here, because for this compound one does not exist in the way regulated drugs have. We report what research and regulators actually say, and nothing more.

What it is

CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH) designed to prompt the pituitary to release growth hormone. The "DAC" version adds a drug-affinity complex that extends its action; it is frequently paired with ipamorelin.

The evidence, stated plainly

Human evidence is very limited, mostly small pharmacology studies showing it can raise GH and IGF-1 levels; there are no large controlled trials establishing benefit, safety, or dosing for body composition or anti-aging use. It is not approved and is prohibited in sport.

Why we grade this “Animal-only”

Evidence is largely preclinical (animal/in-vitro). We label evidence by its strongest honest tier, never by a vendor’s enthusiasm.

Half-life & timing

Plain CJC-1295 acts briefly; the DAC form binds albumin to extend its half-life substantially, which is why the two versions are dosed differently. Human figures are sparse.

Regulatory status

Not FDA-approved for any indication. Sold as a research chemical, prohibited in sport, and with no established human dosing standard.

Storage & handling

Standard peptide handling: lyophilized cold storage, reconstituted with bacteriostatic water, refrigerated and used within a few weeks, never shaken or frozen once mixed.

The math is the dangerous part

Whatever dose a protocol or provider gave you, converting it to syringe units is where errors turn into 10× mistakes. Our calculator does only that conversion — it never invents the dose.

Open the reconstitution calculator

The honest bottom line

CJC-1295 can measurably raise GH and IGF-1, but "changes a lab value" is not the same as "proven safe and effective." With minimal human data and no approval, any protocol you see is convention, not evidence.

Sources

  1. Small human pharmacology studies of CJC-1295 on GH/IGF-1.
  2. Regulatory status references (not FDA-approved; sport-prohibited).
  3. Peptide handling/storage protocols.

Sourcing reflects literature available at publication and may change. See How We Rate Evidence.

← PREVIOUSRetatrutideNEXT →Ipamorelin